BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11396700)

  • 1. Sodium iodide symporter in health and disease.
    Shen DH; Kloos RT; Mazzaferri EL; Jhian SM
    Thyroid; 2001 May; 11(5):415-25. PubMed ID: 11396700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance].
    Spitzweg C
    Internist (Berl); 2003 Apr; 44(4):396-402, 404-8, 410-1. PubMed ID: 12914397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium iodide symporter-based strategies for diagnosis and treatment of thyroidal and nonthyroidal malignancies.
    Heufelder AE; Morgenthaler N; Schipper ML; Joba W
    Thyroid; 2001 Sep; 11(9):839-47. PubMed ID: 11575853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A perspective view of sodium iodide symporter research and its clinical implications.
    Riesco-Eizaguirre G; Santisteban P
    Eur J Endocrinol; 2006 Oct; 155(4):495-512. PubMed ID: 16990649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
    Schmutzler C; Köhrle J
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium iodide symporter: its role in nuclear medicine.
    Chung JK
    J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The practical relevance of the sodium iodide symporter].
    Spitzweg C
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():25-32. PubMed ID: 15255310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune response to the iodide transporter.
    Spitzweg C; Morris JC
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):389-98, viii. PubMed ID: 10874536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa.
    Spitzweg C; Joba W; Eisenmenger W; Heufelder AE
    J Clin Endocrinol Metab; 1998 May; 83(5):1746-51. PubMed ID: 9589686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sodium iodide symporter: its pathophysiological and therapeutic implications.
    Spitzweg C; Morris JC
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):559-74. PubMed ID: 12390328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake.
    Fletcher A; Read ML; Thornton CEM; Larner DP; Poole VL; Brookes K; Nieto HR; Alshahrani M; Thompson RJ; Lavery GG; Landa I; Fagin JA; Campbell MJ; Boelaert K; Turnell AS; Smith VE; McCabe CJ
    Cancer Res; 2020 Jan; 80(1):102-115. PubMed ID: 31672844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Journey of the iodide transporter NIS: from its molecular identification to its clinical role in cancer.
    Riedel C; Dohán O; De la Vieja A; Ginter CS; Carrasco N
    Trends Biochem Sci; 2001 Aug; 26(8):490-6. PubMed ID: 11504625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Na+/I- symporter (NIS): recent advances.
    Levy O; De la Vieja A; Carrasco N
    J Bioenerg Biomembr; 1998 Apr; 30(2):195-206. PubMed ID: 9672241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.
    De La Vieja A; Dohan O; Levy O; Carrasco N
    Physiol Rev; 2000 Jul; 80(3):1083-105. PubMed ID: 10893432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.
    Dohán O; Carrasco N
    Mol Cell Endocrinol; 2003 Dec; 213(1):59-70. PubMed ID: 15062574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sodium iodide symporter in physiology and diseases -- the current state of knowledge].
    Wolny M; Syrenicz A
    Endokrynol Pol; 2007; 58(6):512-21. PubMed ID: 18205108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium iodide symporter (NIS) gene expression in human placenta.
    Mitchell AM; Manley SW; Morris JC; Powell KA; Bergert ER; Mortimer RH
    Placenta; 2001; 22(2-3):256-8. PubMed ID: 11170832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.